Skip to content

Investigating Neural Processing of Social Stimuli

Investigating Neural Processing of Social Stimuli: Investigating a Neurobehavioral Mechanism of Paranoia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03380260
Enrollment
70
Registered
2017-12-21
Start date
2017-06-01
Completion date
2019-04-01
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Brief summary

The primary goal of the present study is to test whether neural activity in brain regions associated with processing threat and social stimuli may underlie paranoid thinking.

Detailed description

Paranoia is a prominent symptom of psychosis that occurs in several other diagnoses, as well as the general population, and that is associated with significant distress and impairment. Previous research suggests that increased baseline activity of the amygdala and related neural circuits may serve as a mechanism for paranoid ideation. This exploratory study will use a paranoia induction procedure in healthy individuals who vary in pre-existing levels of paranoid ideation to test whether increases in self-reported paranoia are accompanied by increases in resting cerebral blood flow (CBF), decreased stimulus-driven neural activity in social processing networks, and increased behavioral perceptions of untrustworthiness. Participants will be randomly assigned to participate in a paranoia induction procedure or a control condition and will then complete neuroimaging and behavioral assessments.

Interventions

BEHAVIORALParanoia Induction

Behavioral procedure involving social exclusion and negative feedback to induce paranoia

Sponsors

The University of Texas at Dallas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* between the ages of 18 and 55

Exclusion criteria

* current psychiatric diagnosis * current use of psychotropic medications * history of head trauma with loss of consciousness for more than 15 minutes * presence of neurological or neurodegenerative disorder * sensory impairments that preclude assessment * presence of intellectual disability * contraindications for MRI (e.g., metallic implants or pregnancy)

Design outcomes

Primary

MeasureTime frameDescription
Resting cerebral blood flow (CBF)CBF measurements will be obtained during the study visit and will last approximately 9 minutes.CBF in amygdala and related neural circuits

Secondary

MeasureTime frameDescription
Amount of Neural ActivityMeasurements will be obtained during the study visit and will last approximately 25 minutes.Task-related activation of amygdala and related neural circuits measured with blood-oxygenation-level-dependent imaging
Ratings of TrustworthinessData will be obtained during the study visit and will last approximately 12 minutes.Behavioral perceptions of the trustworthiness of others
Self-reported paranoid ideationData will be obtained during the study visit and will last approximately 5 minutes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026